Warning: The NCBI web site requires JavaScript to function. more...
Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.
Whyte J, Bergin O, Bianchi A, McNally S, Martin F.
Breast Cancer Res. 2009;11(5):209. Epub . Review.
Related citations
Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
Cancer Res. 2001 Sep 1;61(17):6569-76.
MAPK signalling: ERK5 versus ERK1/2.
Nishimoto S, Nishida E.
EMBO Rep. 2006 Aug;7(8):782-6. Review.
p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
Kim MS, Lee EJ, Kim HR, Moon A.
Cancer Res. 2003 Sep 1;63(17):5454-61.
The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
Gardner HP, Ha SI, Reynolds C, Chodosh LA.
Cancer Res. 2000 Oct 1;60(19):5571-7.
Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways.
Lange CA, Richer JK, Shen T, Horwitz KB.
J Biol Chem. 1998 Nov 20;273(47):31308-16.
Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG.
Cancer Res. 2004 Jul 1;64(13):4637-47.
Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF.
Xing C, Imagawa W.
Carcinogenesis. 1999 Jul;20(7):1201-8.
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W, Liang Q, Balzar S, Wenzel S, Gorska M, Alam R.
J Allergy Clin Immunol. 2008 Apr;121(4):893-902.e2.
The role of mitogen-activated protein (MAP) kinase in breast cancer.
Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, Yue W.
J Steroid Biochem Mol Biol. 2002 Feb;80(2):239-56. Review.
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.
Gee JM, Robertson JF, Ellis IO, Nicholson RI.
Int J Cancer. 2001 Jul 20;95(4):247-54.
Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells.
Sylvester PW, Nachnani A, Shah S, Briski KP.
Asia Pac J Clin Nutr. 2002;11 Suppl 7:S452-9.
Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer.
Wang HY, Cheng Z, Malbon CC.
Cancer Lett. 2003 Mar 10;191(2):229-37.
A bidirectional "alpha(v)beta(3) integrin-ERK1/ERK2 MAPK" connection regulates the proliferation of breast cancer cells.
Vellon L, Menendez JA, Lupu R.
Mol Carcinog. 2006 Oct;45(10):795-804.
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA, Vellon L, Colomer R, Lupu R.
Int J Cancer. 2005 May 20;115(1):19-35.
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W, Pew T, Zou M, Pang D, Conzen SD.
J Biol Chem. 2005 Feb 11;280(6):4117-24. Epub 2004 Dec 7.
Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways.
Ip WK, Wong CK, Lam CW.
Clin Exp Immunol. 2006 Jul;145(1):162-72.
Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
Cancer Res. 2001 Sep 15;61(18):6747-54.
MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition.
Pinkas J, Leder P.
Cancer Res. 2002 Aug 15;62(16):4781-90.
Transforming growth factor-beta-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38beta mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation.
Sebe A, Leivonen SK, Fintha A, Masszi A, Rosivall L, Kähäri VM, Mucsi I.
Nephrol Dial Transplant. 2008 May;23(5):1537-45. Epub 2008 Jan 11.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on